Bausch & Lomb Corp Executive's Stock Award

On August 5, 2025, Yehia Hashad, Executive Vice President of R&D and Chief Medical Officer of Bausch & Lomb Corp, was awarded 17,715 common shares of the company. These shares are part of a performance stock unit (PSU) award granted on March 1, 2023, under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. The PSUs were earned at the target performance level (100%) and are set to vest on March 1, 2026, contingent on Hashad's continued employment through that date. Following this transaction, Hashad owns a total of 134,454 common shares of Bausch & Lomb Corp.